201 related articles for article (PubMed ID: 2649846)
1. Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential.
Symonds G; Hartshorn A; Kennewell A; O'Mara MA; Bruskin A; Bishop JM
Oncogene; 1989 Mar; 4(3):285-94. PubMed ID: 2649846
[TBL] [Abstract][Full Text] [Related]
2. Tumor progression following transformation of murine monocytes by v-myc: acquisition of immortalization and tumorigenicity.
Stapleton P; Takayama Y; Hartshorn A; Kalaizis A; Rowe PB; Symonds G
Oncogene; 1991 May; 6(5):807-17. PubMed ID: 1711191
[TBL] [Abstract][Full Text] [Related]
3. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
Dolnikov A; Millington M; Sun LQ; Symonds G
Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291
[TBL] [Abstract][Full Text] [Related]
4. The transforming activity of the chicken c-myc gene can be potentiated by mutations.
Frykberg L; Graf T; Vennström B
Oncogene; 1987; 1(4):415-22. PubMed ID: 3330784
[TBL] [Abstract][Full Text] [Related]
5. Generation of macrophage cell line from fresh bone marrow cells with a myc/raf recombinant retrovirus.
Blasi E; Radzioch D; Merletti L; Varesio L
Cancer Biochem Biophys; 1989 Oct; 10(4):303-17. PubMed ID: 2695237
[TBL] [Abstract][Full Text] [Related]
6. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
[TBL] [Abstract][Full Text] [Related]
7. Constitutive expression of exogenous myc in myelomonocytic cells: acquisition of a more transformed phenotype and inhibition of differentiation induction.
Chisholm O; Stapleton P; Symonds G
Oncogene; 1992 Sep; 7(9):1827-36. PubMed ID: 1501891
[TBL] [Abstract][Full Text] [Related]
8. The v-myc oncogene.
Lee CM; Reddy EP
Oncogene; 1999 May; 18(19):2997-3003. PubMed ID: 10378695
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of the carboxy-terminal transforming region of v-Myc: binding to Max is necessary, but not sufficient, for cellular transformation.
Min S; Mascarenhas NT; Taparowsky EJ
Oncogene; 1993 Oct; 8(10):2691-701. PubMed ID: 8378081
[TBL] [Abstract][Full Text] [Related]
10. Cell division is required for expression of v-myc transforming properties in chicken embryonic neuroretina cells.
Bechade C; Calothy G
Oncogene; 1991 Dec; 6(12):2311-7. PubMed ID: 1662792
[TBL] [Abstract][Full Text] [Related]
11. Activation of the M-CSF gene in mouse macrophages immortalized by retroviruses carrying a v-myc oncogene.
Righi M; Sassano M; Valsasnini P; Shammah S; Ricciardi-Castagnoli P
Oncogene; 1991 Jan; 6(1):103-11. PubMed ID: 1825138
[TBL] [Abstract][Full Text] [Related]
12. Transforming ability of Gag-Myc fusion proteins correlates with Gag-Myc protein stability and transcriptional repression.
Law W; Linial ML
Oncogene; 2001 Mar; 20(9):1118-27. PubMed ID: 11314049
[TBL] [Abstract][Full Text] [Related]
13. v-Myc is invariably required to sustain rapid proliferation of infected cells but in stable cell lines becomes dispensable for other traits of the transformed phenotype.
Tikhonenko AT; Black DJ; Linial ML
Oncogene; 1995 Oct; 11(8):1499-508. PubMed ID: 7478574
[TBL] [Abstract][Full Text] [Related]
14. The fms gene and the CSF-1 receptor.
Sherr CJ; Rettenmier CW
Cancer Surv; 1986; 5(2):221-32. PubMed ID: 3022923
[TBL] [Abstract][Full Text] [Related]
15. Oncogene-mediated multistep transformation of C3H10T1/2 cells.
Taparowsky EJ; Heaney ML; Parsons JT
Cancer Res; 1987 Aug; 47(15):4125-9. PubMed ID: 3300959
[TBL] [Abstract][Full Text] [Related]
16. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.
Schreiner S; Birke M; García-Cuéllar MP; Zilles O; Greil J; Slany RK
Cancer Res; 2001 Sep; 61(17):6480-6. PubMed ID: 11522644
[TBL] [Abstract][Full Text] [Related]
17. Murine c-myc retroviruses alter the growth requirements of myeloid cell lines.
Cory S; Bernard O; Bowtell D; Schrader S; Schrader JW
Oncogene Res; 1987 Jun; 1(1):61-76. PubMed ID: 3329710
[TBL] [Abstract][Full Text] [Related]
18. Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus.
Dyall-Smith D; Cory S
Oncogene Res; 1988 May; 2(4):403-9. PubMed ID: 2840624
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis in v-myc transformation of myelomonocytic cells and its modulation by CSF-1.
Dolnikov A; Ward RL; Hawkins NJ; Symonds G
Oncogene; 1996 Mar; 12(6):1189-98. PubMed ID: 8649820
[TBL] [Abstract][Full Text] [Related]
20. The myb oncogene.
Lipsick JS; Baluda MA
Gene Amplif Anal; 1986; 4():73-98. PubMed ID: 3333362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
